We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
uniQure
QURE
$3.14B
| $566K | ﹤0.01% |
+15,672
| New | +$661K |
|
1102
Cheesecake Factory
CAKE
$5.73B
| $565K | ﹤0.01% |
15,249
-8,677
| -36% | -$298K |
|
|
PDCE
1103
DELISTED
PDC Energy, Inc.
PDCE
| $563K | ﹤0.01% |
+27,439
| New | +$429K |
|
1104
Raymond James Financial
RJF
$34.5B
| $558K | ﹤0.01% |
+8,754
| New | +$501K |
|
1105
Regenxbio
RGNX
$710M
| $554K | ﹤0.01% |
+12,224
| New | +$427K |
|
|
MBT
1106
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $550K | ﹤0.01% |
61,436
+28,694
| +88% | +$243K |
|
1107
Smith & Wesson
SWBI
$640M
| $548K | ﹤0.01% |
30,856
+1,393
| +5% | +$23K |
|
1108
Western Union
WU
$2.26B
| $544K | ﹤0.01% |
+24,810
| New | +$538K |
|
|
PINC
1109
DELISTED
Premier
PINC
| $537K | ﹤0.01% |
15,285
-251
| -2% | -$8.66K |
|
1110
Sabra Healthcare REIT
SBRA
$5.22B
| $537K | ﹤0.01% |
+30,901
| New | +$493K |
|
1111
Commercial Metals
CMC
$7.99B
| $535K | ﹤0.01% |
+26,050
| New | +$541K |
|
1112
Elanco Animal Health
ELAN
$11.3B
| $535K | ﹤0.01% |
17,429
-117,545
| -87% | -$3.59M |
|
|
VNE
1113
DELISTED
Veoneer, Inc.
VNE
| $530K | ﹤0.01% |
+24,888
| New | +$471K |
|
|
SRCL
1114
DELISTED
Stericycle Inc
SRCL
| $523K | ﹤0.01% |
+7,541
| New | +$516K |
|
1115
ICU Medical
ICUI
$4.53B
| $517K | ﹤0.01% |
2,412
-20,918
| -90% | -$4.06M |
|
1116
Kinsale Capital Group
KNSL
$8.5B
| $516K | ﹤0.01% |
2,577
-12,229
| -83% | -$2.68M |
|
1117
Freshpet
FRPT
$3.47B
| $514K | ﹤0.01% |
3,620
-8,562
| -70% | -$1.11M |
|
1118
Qfin Holdings
QFIN
$1.52B
| $513K | ﹤0.01% |
+43,470
| New | +$520K |
|
1119
Magnolia Oil & Gas
MGY
$6.14B
| $512K | ﹤0.01% |
+72,582
| New | +$433K |
|
1120
Funko
FNKO
$340M
| $510K | ﹤0.01% |
+49,116
| New | +$405K |
|
1121
Terex
TEX
$7.75B
| $509K | ﹤0.01% |
14,581
-29,389
| -67% | -$868K |
|
1122
Murphy USA
MUSA
$10.2B
| $505K | ﹤0.01% |
3,856
-7,873
| -67% | -$1.01M |
|
|
TBI
1123
Trueblue
TBI
$306M
| $501K | ﹤0.01% |
26,818
-49,584
| -65% | -$892K |
|
1124
First Financial Bancorp
FFBC
$3.6B
| $500K | ﹤0.01% |
28,528
-115,521
| -80% | -$1.81M |
|
1125
Ocular Therapeutix
OCUL
$2.24B
| $498K | ﹤0.01% |
+24,060
| New | +$357K |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.